Latest AI and machine learning research in skin cancer for healthcare professionals.
BACKGROUND: Combination immune checkpoint inhibitors are recommended as first-line therapy for advan...
PURPOSE: Immune checkpoint blockade (ICB) benefits only a subset of sarcoma patients. Biomarkers of ...
The immune evasion that is encouraged by the tumor microenvironment (TME) is a key factor in the fai...
Prussian blue nanoparticles (PBNPs) are a versatile platform for administering photothermal therapy ...
Interactions between cells are central to tissue organization and function in health and disease. La...
Early detection of esophageal cancer (EC) remains a major challenge due to the limited understanding...
Melanoma remains one of the most aggressive and lethal cutaneous malignancies, underscoring the need...
The tumor immune microenvironment and intratumoral microbiota play critical roles in cancer progress...
Tubulin is a validated anticancer target, yet the clinical translation of colchicine-binding site in...
BACKGROUND: Spatial proteogenomics marks a paradigm shift in oncology by integrating molecular analy...
Nail diseases, including such common conditions as fungus, and more serious issues like melanoma, ma...
PURPOSE: Programmed cell death ligand-1 (PD-L1) is a key prognostic and predictive biomarker for imm...
Cancer immunotherapies trigger highly variable responses in patients and in genetically identical mo...
This review examines how biotechnology advances (CRISPR/Cas9, next-generation targeted therapies, na...
Esophageal squamous cell carcinoma (ESCC) remains a major health burden, particularly in Asia, with ...
Hepatocellular carcinoma (HCC), the predominant form of primary liver cancer, ranks as the fourth le...
Tumor Mutational Burden (TMB) is a widely used biomarker for selecting cancer patients for immune ch...
Immune checkpoint inhibitors (ICI) have improved clinical outcomes for some patients with advanced N...
PURPOSE OF REVIEW: Early diagnosis of skin cancer is essential for patient care. Noninvasive skin im...
The epidermal growth factor receptor (EGFR) is a key target in cancer therapy, mainly in non-small c...
The discovery of natural killer (NK) cells stands among the fundamental milestones in modern immunol...